Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has just been granted a new patent for its innovative Mont-Blanc MIS range in the USA.
The United States Patent and Trademark Office (USPTO) has issued Spineway a new patent for its minimally invasive surgery technology, Mont-Blanc MIS.
Launched at the end of 2016, the Mont-Blanc MIS range is currently the second best-selling range of the Group. This range offers surgeons unique technical features that make the surgical procedure more efficient but also safer in way to improve the treatment of severe pathologies of the spine.
With 15% of its turnover devoted to research and development, Spineway confirms its ability to market innovative products in the spine surgery sector.